Literature DB >> 1804655

Pharmacokinetics of intramuscular nicomorphine and its metabolites in man.

P M Koopman-Kimenai1, T B Vree, L H Booij, R Dirksen, G M Nijhuis.   

Abstract

After i.m. injection nicomorphine is relatively slowly absorbed from the muscular depot and is found in the serum for approximately 1 h. The rate of absorption differs between patients and governs the overall pharmacokinetic profile of the compound. The relative AUCs were nicomorphine 18%, 6-nicotinoylmorphine 17%, and morphine 65%. Nicomorphine and 6-nicotinoylmorphine have significantly higher AUCs after i.m. injection than after i.v. injection, while the AUC of morphine and the total AUC show no difference between the two modes of administration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1804655     DOI: 10.1007/BF00314971

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  High-performance liquid chromatography and preliminary pharmacokinetics of nicomorphine and its metabolites 3-nicotinoyl- and 6-nicotinoylmorphine and morphine.

Authors:  P M Koopman-Kimenai; T B Vree; M W Cress-Tijhuis; L H Booy; G Drijkoningen
Journal:  J Chromatogr       Date:  1987-05-15

2.  Analgesic effect of morphine glucuronides.

Authors:  K Shimomura; O Kamata; S Ueki; S Ida; K Oguri; H Yoshimura; H Tsukamoto
Journal:  Tohoku J Exp Med       Date:  1971-09       Impact factor: 1.848

Review 3.  Opiate structure and activity--a guide to understanding the receptor.

Authors:  D H Thorpe
Journal:  Anesth Analg       Date:  1984-02       Impact factor: 5.108

4.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.

Authors:  J Säwe; L Kager; J O Svensson Eng; A Rane
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

5.  Pharmacokinetics of morphine injected intravenously into the anesthetized dog.

Authors:  C C Hug; M R Murphy; E P Rigel; W A Olson
Journal:  Anesthesiology       Date:  1981-01       Impact factor: 7.892

6.  Kinetics of high-dose intravenous morphine in cardiac surgery patients.

Authors:  D R Stanski; D J Greenblatt; D G Lappas; J Koch-Weser; E Lowenstein
Journal:  Clin Pharmacol Ther       Date:  1976-06       Impact factor: 6.875

7.  Pharmacokinetics of intravenously administered nicomorphine and its metabolites in man.

Authors:  P M Koopman-Kimenai; T B Vree; L H Booij; R Dirksen; G M Nijhuis
Journal:  Eur J Anaesthesiol       Date:  1993-03       Impact factor: 4.330

8.  Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.

Authors:  R Osborne; S Joel; D Trew; M Slevin
Journal:  Clin Pharmacol Ther       Date:  1990-01       Impact factor: 6.875

9.  Morphine kinetics in cancer patients.

Authors:  J Säwe; B Dahlström; L Paalzow; A Rane
Journal:  Clin Pharmacol Ther       Date:  1981-11       Impact factor: 6.875

10.  CSF and plasma pharmacokinetics of intramuscular morphine.

Authors:  G Nordberg; L Borg; T Hedner; T Mellstrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  1 in total

1.  Rectal administration of nicomorphine in patients improves biological availability of morphine and its glucuronide conjugates.

Authors:  P M Koopman-Kimenai; T B Vree; L H Booij; R Dirksen
Journal:  Pharm World Sci       Date:  1994-12-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.